<- Go Home

Bumrungrad Hospital Public Company Limited

Bumrungrad Hospital Public Company Limited owns and operates healthcare-related entities in Thailand and internationally. It operates allergy, arrhythmia, behavioral health, breast, home service, heart valve, robotic surgery, rehabilitation, children's, colorectal surgery, complex coronary artery intervention, cornea transplant, dental, diagnostic, dialysis, digestive disease, ear, nose, throat, emergency, endocrinology, diabetes, expatriate liaison, eye, fertility, gastrointestinal motility, health screening, holistic wound care, horizon regional cancer, hyperbaric oxygen therapy, nephrology, neuroscience, orthopedics, perinatal, plastic surgery, pulmonary, refractive surgery, robotic scoliosis, skin, sports medicine and joint, surgery, travel medicine, urology, scientific wellness, skin and aesthetic, and women's centers. The company also operates breastfeeding, Yangon, COVID-19 recovery, comprehensive sleep, IVF, hearing and balance, medical, memory, new life healthy aging, Parkinson's disease and movement disorders, pride, surgery, vaccine clinics. In addition, it provides spine institute, diagnostic radiology and nuclear medicine, esperance, heart institute, intensive care unit, neurocritical care, nutrition services, pharmacy services, and preventive genomics and integrative medicine services. Further, the company offers clinical research; hospital consulting and management; healthcare personnel development and training; healthcare referral; and digital platform services. Additionally, it is involved in the distribution of pharmaceutical and medical goods in specialized stores; development of software for healthcare services; holding of real estate assets; and manufacture and sale of vitamin supplements. Bumrungrad Hospital Public Company Limited was founded in 1975 and is based in Bangkok, Thailand.

Market Cap

THB 218.6B

Volume

2.7M

Cash and Equivalents

THB 3.9B

EBITDA

THB 10.1B

Tax Rate Collected

N/A

Tax Rate Ratio

N/A

Gross Profit

THB 13.4B

Profit Margin

50.95%

52 Week High

THB 284.00

52 Week Low

THB 212.00

Dividend

1.87%

Price / Book Value

8.66

Price / Earnings

31.39

Price / Tangible Book Value

8.88

Enterprise Value

THB 208.0B

Enterprise Value / EBITDA

20.62

Operating Income

THB 9.1B

Return on Equity

32.51%

Return on Assets

20.30

Cash and Short Term Investments

THB 11.1B

Debt

THB 138.4M

Equity

THB 25.6B

Revenue

THB 26.2B

Unlevered FCF

THB 4.9B

Sector

Health Care Providers and Services

Category

N/A

Hedge Funds that own this stock

PREMIUM

Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).

Upgrade to Yellowbrick Premium

Yellowbrick Portfolios that own this stock

PREMIUM

Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).

Upgrade to Yellowbrick Premium

Company Stock Pitches